These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9796914)

  • 1. Reciprocal regulation of protein tyrosine kinases p56lck and p59fyn, and altered tyrosine phosphorylation in murine AIDS.
    Trebak M; Lambert CA; Rahmouni S; Greimers R; Boniver J; Moutschen M
    Int Immunol; 1998 Oct; 10(10):1473-80. PubMed ID: 9796914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective protein tyrosine phosphorylation and altered levels of p59fyn and p56lck in CD4 T cells from HIV-1 infected patients.
    Cayota A; Vuillier F; Siciliano J; Dighiero G
    Int Immunol; 1994 Apr; 6(4):611-21. PubMed ID: 7912546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fyn and Lck tyrosine kinases regulate tyrosine phosphorylation of p105CasL, a member of the p130Cas docking protein family, in T-cell receptor-mediated signalling.
    Kanda H; Mimura T; Hamasaki K; Yamamoto K; Yazaki Y; Hirai H; Nojima Y
    Immunology; 1999 May; 97(1):56-61. PubMed ID: 10447714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related impairment of p56lck and ZAP-70 activities in human T lymphocytes activated through the TcR/CD3 complex.
    Fülöp T; Gagné D; Goulet AC; Desgeorges S; Lacombe G; Arcand M; Dupuis G
    Exp Gerontol; 1999 Apr; 34(2):197-216. PubMed ID: 10363787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
    Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
    J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction molecules.
    Liu J; Finke J; Krauss JC; Shu S; Plautz GE
    Cancer Immunol Immunother; 1998 Jul; 46(5):268-76. PubMed ID: 9690455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
    Burgess KE; Yamamoto M; Prasad KV; Rudd CE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia.
    Hubert P; Bergeron F; Ferreira V; Seligmann M; Oksenhendler E; Debre P; Autran B
    Int Immunol; 2000 Apr; 12(4):449-57. PubMed ID: 10744646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in the specific activity of p50csk in proliferating T cells correlates with decreased specific activity of p56lck and p59fyn and reduced phosphorylation of CD3 subunits.
    Orchansky PL; Ng DH; Johnson P; Teh HS
    Mol Immunol; 1996 Apr; 33(6):531-40. PubMed ID: 8700169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4-dependent and -independent association of protein tyrosine kinases to the T cell receptor/CD3 complex of CD4+ mouse T lymphocytes.
    Criado G; Feito MJ; Rojo JM
    Eur J Immunol; 1996 Jun; 26(6):1228-34. PubMed ID: 8647197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human airway epithelial cells stimulate T-lymphocyte lck and fyn tyrosine kinase.
    Kalb TH; Yio XY; Mayer L
    Am J Respir Cell Mol Biol; 1997 Nov; 17(5):561-70. PubMed ID: 9374107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of p56lck and p59fyn are reduced by a glucocorticoid-dependent mechanism in graft-versus-host reaction-induced T cell anergy.
    Desbarats J; You-Ten KE; Lapp WS
    Cell Immunol; 1995 Jun; 163(1):10-8. PubMed ID: 7758119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn.
    Quill H; Riley MP; Cho EA; Casnellie JE; Reed JC; Torigoe T
    J Immunol; 1992 Nov; 149(9):2887-93. PubMed ID: 1357030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide stimulates p59fyn kinase activity in murine thymocytes.
    Xin Z; Sun L; Ganea D
    Peptides; 1997; 18(8):1151-9. PubMed ID: 9396055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR signals mediated by Src family kinases are essential for the survival of naive T cells.
    Seddon B; Zamoyska R
    J Immunol; 2002 Sep; 169(6):2997-3005. PubMed ID: 12218114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.
    Levey DL; Srivastava PK
    J Exp Med; 1995 Oct; 182(4):1029-36. PubMed ID: 7561676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role for p59(fyn) in CD2-based signal transduction.
    Fukai I; Hussey RE; Sunder-Plassmann R; Reinherz EL
    Eur J Immunol; 2000 Dec; 30(12):3507-15. PubMed ID: 11093170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-zeta, and ZAP-70.
    Stone JD; Conroy LA; Byth KF; Hederer RA; Howlett S; Takemoto Y; Holmes N; Alexander DR
    J Immunol; 1997 Jun; 158(12):5773-82. PubMed ID: 9190928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential involvement of protein tyrosine kinases p56lck and p59fyn in T cell development.
    van Oers NS; Garvin AM; Cooke MP; Davis CB; Littman DR; Perlmutter RM; Teh HS
    Adv Exp Med Biol; 1992; 323():89-99. PubMed ID: 1485568
    [No Abstract]   [Full Text] [Related]  

  • 20. TGF-beta abrogates TCR-mediated signaling by upregulating tyrosine phosphatases in T cells.
    Choudhry MA; Sir O; Sayeed MM
    Shock; 2001 Mar; 15(3):193-9. PubMed ID: 11236902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.